World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01246882
Date of registration: 22/11/2010
Prospective Registration: Yes
Primary sponsor: University of California, Los Angeles
Public title: Stroke Inpatient Rehabilitation Reinforcement of ACTivity SIRRACT
Scientific title: Stroke Inpatient Rehabilitation Reinforcement of ACTivty: An International Multisite Clinical Trial
Date of first enrolment: January 2011
Target sample size: 140
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01246882
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  Phase 3
Countries of recruitment
Egypt India Ireland Italy Japan Korea, Republic of New Zealand Nigeria
Spain Taiwan Turkey United States
Contacts
Name:     Bruce H Dobkin, MD
Address: 
Telephone:
Email:
Affiliation:  University of California, Los Angeles
Key inclusion & exclusion criteria

Inclusion Criteria:

- Admission for acute inpatient rehabilitation of a first stroke (or second stroke after
full recovery from prior TIA/Stroke)

- Time from onset of stroke to admission for rehabilitation < 35 days

- Stroke from any cause (thrombotic infarct, cardioembolus, intracerebral hemorrhage)
that includes unilateral hemiparesis. Hemiparesis means less than / equal to 4/5
strength by the British Medical Council scale for hip flexion tested supine and for
knee or ankle flexion and extension (scores less than / equal to 22 of 25 possible
points)

- Ability to follow simple instructions, especially to understand verbal reinforcement
about activity.

- Independent in mobility prior to admission by the Barthel Index.

- Able to walk with no more than physical assistance of 2 persons for at least 5 steps
(for example, 3 strides of the left leg alternating with 2 on the right leg). Subjects
can use any type of assistive device and brace needed.

- Able to understand and repeat information related to the Informed Consent. The subject
signs a Consent form.

Exclusion Criteria:

- Current medical disease that will limit physical therapy at the time of randomization
or limited walking prior to the stroke, such as serious infection, DVT, orthostatic
hypotension, > stage 2 decubitus ulcer of buttocks or legs, congestive heart failure,
claudication, and pain with weight-bearing or walking. Subjects can be entered if a
complication resolves within 7 days of admission screening.

- Aphasia with inability to follow 2-step directions during therapeutic instructions or
answers Yes/No to questions with < 75% accuracy related to personal health and
symptoms.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Stroke
Intervention(s)
Behavioral: Augmented activity feedback
Behavioral: Speed-only feedback
Primary Outcome(s)
Gait speed [Time Frame: Discharge]
Secondary Outcome(s)
Distance walked in 3 minutes [Time Frame: Discharge]
Secondary ID(s)
10-000134
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ain Shams University
Gazi University
University College Hospital, Ibadan, Nigeria
University of Vigo
Burke Rehabilitation Hospital
Chonnam National University Hospital
IRCCS San Raffaele
Morinomiya Hospital, Osaka, Japan
St. Luke's Hospital, Pennsylvania
Washington University School of Medicine
IRCCS San Camillo, Venezia, Italy
Rehabilitation Hospital, Barcelona, Spain
Burwood Hospital, Christchurch, New Zealand
Father Muller Medical College
Mayo Clinic
MedStar National Rehabilitation Network
National Taiwan University Hospital
Fairlawn Hospital, Worcester, MA, USA
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history